• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

MPM Capital

edit

Unique to MPM is an internal team of industry experts that has been specifically assembled not only to enable MPM to assess opportunities but to participate in the value creation and value enhancing acitivites once MPM is an investor. They believe that there senior team is the broadest and deepest team in healthcare venture capital, comprised of talented individuals with impressive investing and finance pedigrees, as well as persons who possess specific functional and operating expertise. MPM executives have and will continue to take interim operating positions in portfolio companies. They can “drop in” expertises in chemistry or biology, intellectual property, licensing and business development, clinical trial design and execution, and commercial operations. Whether we are helping build a company, filling in short-term management gaps, or working alongside management to prepare for key value-creating events, they do whatever it takes to help there companies succeed.

Recent Milestones

edit

• 
  MPM Capital invested in Radius Health. (4/25/13)
  Posted 4/26/13 at 9:44pm via yahoo.com
• 
  MPM Capital invested in Theraclone Sciences. (3/25/13)
  Posted 3/25/13 at 8:12pm via finsmes.com
• 
  MPM Capital invested in Nevro. (3/7/13)
  Posted 3/7/13 at 6:40pm via finsmes.com
• 
  MPM Capital invested in 23andMe. (12/10/12)
  Posted 1/4/13 at 8:46am via venturebeat.com
• 
  MPM Capital invested in Rhythm Pharmaceuticals. (11/27/12)
  Posted 11/27/12 at 7:45pm via pehub.com
• 
  MPM Capital invested in Selexys Pharmaceuticals Corporation. (9/20/12)
  Posted 9/19/12 at 7:39pm via yahoo.com
• 
  MPM Capital invested in Vascular Pharmaceuticals. (9/12/12)
  Posted 9/12/12 at 7:41pm via finsmes.com
• 
  MPM Capital invested in Chiasma. (7/23/12)
  Posted 7/23/12 at 6:18pm via finsmes.com
• 
  MPM Capital invested in Rhythm Pharmaceuticals. (6/13/12)
  Posted 6/13/12 at 6:14pm via rhythmtx.com
• 
  MPM Capital invested in Astute Medical. (6/7/12)
  Posted 6/7/12 at 6:26pm via finsmes.com
• 
  MPM Capital invested in TriVascular. (6/4/12)
  Posted 6/4/12 at 3:26am via yahoo.com
• 
  MPM Capital invested in Celladon. (5/8/12)
  Posted 5/8/12 at 6:55pm via finsmes.com
• 
  MPM Capital invested in Radius Health. (2/13/12)
  Posted 2/13/12 at 3:07am via onbiovc.com
• 
  MPM Capital invested in Aratana Therapeutics. (12/7/11)
  Posted 12/7/11 at 3:43am via finsmes.com
• 
  MPM Capital invested in Verastem. (11/11/11)
  Posted 11/11/11 at 6:29pm via masshightech.com
• 
  MPM Capital invested in Valeritas. (9/12/11)
  Posted 9/12/11 at 5:48pm via finsmes.com

Investments

Videos

Sources

1. MPM Capital raises $550M healthcare fund (venturebeat.com) [edit]
2. MPM BioVentures ups fund to $140M (masshightech.com) [edit]
3. Radius Health Completes $43 Million Financing to Advance BA058 for the Treatment of Osteoporosis (finance.yahoo.com) [edit]
4. Theraclone Sciences Closes $14M in Series B and Debt Financing (finsmes.com) [edit]
5. Nevro Raises $48M in Series C Financing (finsmes.com) [edit]
6. venturebeat.com [edit]
7. Rhythm Adds $8M to Cap Series B at $33M (pehub.com) [edit]
8. Selexys Pharmaceuticals Completes $23M Equity Financing and Signs Agreement With Global Pharmaceutical Company (finance.yahoo.com) [edit]
9. Vascular Pharmaceuticals Completes $16M Series A Equity Financing (finsmes.com) [edit]
10. Chiasma Closes $38.5M Series D Equity Financing (finsmes.com) [edit]
11. Rhythm Raises $25M in Series B Financing for Diabetes and Obesity Therapeutics (rhythmtx.com) [edit]
12. Astute Medical Completes $40.4M Series C Financing (finsmes.com) [edit]
13. TriVascular Secures $60 Million in Equity Financing (news.yahoo.com) [edit]
14. Celladon Raises Additional $10M (finsmes.com) [edit]
15. Radius Health, Inc.: Series C $21.4M (onbiovc.com) [edit]
16. Aratana Therapeutics Closes $15M Series B Financing (finsmes.com) [edit]
17. Verastem, with IPO planned, raises $20M in funding (masshightech.com) [edit]
18. Valeritas Raises $150m in Series C financing. (finsmes.com) [edit]
19. Radius Health, Inc.: Series C $66M (onbiovc.com) [edit]
20. Nevro Completes $58M Financing (finsmes.com) [edit]
21. Verastem rounds up $32M in second funding (masshightech.com) [edit]
22. Conatus Pharmaceuticals Completes the Second Closing of its Series B Private Placement Financing (money.msn.com) [edit]
23. Aratana Therapeutics Closes $20 Series A Financing (finsmes.com) [edit]
24. Verastem Closes $16M Series A Financing (finsmes.com) [edit]
25. IPierian Announces Second Close Of Series B Financing At $28M (fis.dowjones.com) [edit]
26. TriVascular, Inc.: Series C $60M (onbiovc.com) [edit]
27. Big Pharma firms back $43M round for NeuroTherapeutics (fiercebiotech.com) [edit]
28. Theraclone Raises $1.5M (xconomy.com) [edit]
29. Syndax Pharmaceuticals, Inc.: Series A $9M (onbiovc.com) [edit]
30. Rhythm Pharma raises $21M for metabolic diseases (fiercebiotech.com) [edit]
31. http://www.fiercebiotech.com/story/alnara-grabs-35m-vc-cash-it-aims-nda/2010-01-28?utm_medium=rss&utm_source=rss&cmp-id=OTC-RSS-FB0 (fiercebiotech.com) [edit]
32. EndoGastric Solutions, Inc.: Series E $21.5M (onbiovc.com) [edit]
33. Oxagen rounds up $26.7M in VC (fiercebiotech.com) [edit]
34. TriVascular (trivascular2.com) [edit]
35. PrimeraDx, Inc.: Series C $20M (onbiovc.com) [edit]
36. Xconomy Seattle (xconomy.com) [edit]
37. Epizyme pulls in $32M in VC capital, new investors (fiercebiotech.com) [edit]
38. PharmAthene, Inc. Announces $19.3 Million Private Placement of Convertible Notes and Common Stock Warrants (ir.pharmathene.com) [edit]
39. iZumi Bio and Pierian Merge to Form iPierian to Advance Cellular Reprogramming (biocetera.com) [edit]
40. Xconomy Seattle (xconomy.com) [edit]
41. Xanodyne Pharmaceuticals, Inc.: Series D $38M (onbiovc.com) [edit]
42. Elixir Pharmaceuticals, Inc.: Series D $12M (onbiovc.com) [edit]
43. TaiGen Biotechnology Secures 37 Million USD in Series C Round Financing (reuters.com) [edit]
44. KaloBios Raises Additional $12 Million in Series D Venture Financing for a New Total of $32 Million (kalobios.com) [edit]
45. Radius Raises Additional $15 Million, Increasing Second Private Equity Financing Round to $82.5 Million (radiuspharm.mwnewsroom.com) [edit]
46. ARYx Therapeutics Inc. Announces $21.6 Million Private Placement (investors.aryx.com) [edit]
47. Innovative Spinal Technologies Jilted, Now Bankrupt, Source Says (xconomy.com) [edit]
48. DeviceSpace (devicespace.com) [edit]
49. Boston Scientific spinout TriVascular2 takes in $65M (deals.venturebeat.com) [edit]
50. Allozyne, Inc., Closes $30 Million Series B Financing (allbusiness.com) [edit]
51. Ceregene Partners With Genzyme, Inks $28M Series C (altapartners.com) [edit]
52. Metabolex (Metabolex.com) [edit]
53. Radius Raises $57.5 Million in Second Private Financing Round (radiuspharm.com) [edit]
54. NeoVista, a co. targeting age-related macular degeneration, raises $41M (deals.venturebeat.com) [edit]
55. Elixir raises $46M for fountain of youth (deals.venturebeat.com) [edit]
56. Chiasma Raises $44 Million Series C to Fund Clinical Testing, Advance Technology. (allbusiness.com) [edit]
57. VLST Corporation Raises $55 Million (vlstcorp.com) [edit]
58. MacroGenics Raises $45M in Series C Financing - Company to Advance Monoclonal Antibody Clinical Programs (macrogenics.com) [edit]
59. Allozyne Inc. Raises $3.5 Million in Series A Funding (goodwinprocter.com) [edit]
60. CELLERANT THERAPEUTICS RAISES $16 MILLION TO ADVANCE STEM CELL-BASED THERAPIES FOR LIFE-THREATENING DISEASES (cellerant.com) [edit]
61. Perlegen Raises $74 Million to Apply Pharmacogenomics to Late-Stage Drug Pipeline. (allbusiness.com) [edit]
62. Xconomy Seattle (xconomy.com) [edit]
63. taigenbiotech.com.tw [edit]
64. Xconomy Seattle (xconomy.com) [edit]